|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
03/21/2024 |
$974.75 |
$979.26 |
$968.00 |
$968.01 |
435.10K | 03/22/2024 |
$973.00 |
$977.39 |
$966.47 |
$967.24 |
274.40K | 03/25/2024 |
$954.01 |
$964.98 |
$952.47 |
$961.09 |
322.30K | 03/26/2024 |
$961.99 |
$966.68 |
$957.78 |
$963.55 |
386.80K | 03/27/2024 |
$971.04 |
$976.75 |
$962.41 |
$966.30 |
314.80K |
|
Regeneron Pharmaceuticals is a biotechnology company. Co.'s products include: EYLEA, which is designed for the treatment of neovascular age-related macular degeneration, diabetic macular edema, macular edema, myopic choroidal neovascularization, diabetic retinopathy, neovascular glaucoma and retinopathy of prematurity; Dupixent, which is designed for the treatment of atopic dermatitis, asthma, rhinosinusitis with nasal polyposis, eosinophilic esophagitis (in adults and adolescents) and prurigo nodularis; and Libtayo, which is designed for the treatment of metastatic or locally advanced first-line non-small cell lung cancer and metastatic or recurrent second-line cervical cancer. | |
|
Regeneron Pharmaceuticals (REGN) has the following price history information. Looking back at REGN historical stock prices for the last five trading days, on March 21, 2024, REGN opened at $974.75, traded as high as $979.26 and as low as $968.00, and closed at $968.01. Trading volume was a total of 435.10K shares. On March 22, 2024, REGN opened at $973.00, traded as high as $977.39 and as low as $966.47, and closed at $967.24. Trading volume was a total of 274.40K shares. On March 25, 2024, REGN opened at $954.01, traded as high as $964.98 and as low as $952.47, and closed at $961.09. Trading volume was a total of 322.30K shares. On March 26, 2024, REGN opened at $961.99, traded as high as $966.68 and as low as $957.78, and closed at $963.55. Trading volume was a total of 386.80K shares. On March 27, 2024, REGN opened at $971.04, traded as high as $976.75 and as low as $962.41, and closed at $966.30. Trading volume was a total of 314.80K shares.
REGN Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Regeneron Pharmaceuticals shares, starting with a $10,000 purchase of REGN, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
03/31/2014 |
|
End date: |
03/27/2024 |
|
Start price/share: |
$300.28 |
|
End price/share: |
$966.30 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
221.80% |
|
Average Annual Total Return: |
12.40% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$32,175.41 |
|
Years: |
10.00 |
|
|
|
Date |
Close |
03/21/2024 | $968.01 | 03/22/2024 | $967.24 | 03/25/2024 | $961.09 | 03/26/2024 | $963.55 | 03/27/2024 | $966.30 |
|
|